Recent Quarter Total Invested
$2.41 B
Recent Quarter Institutional Ownership Percentage
98.38%
Total Invested of Last Quarter
$1.74 B
Ownership Percentage of Last Quarter
105.44%
Agios Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 08/14/2024 | 5.65 M | $243.82 M | 1.14% | 9.95% |
| VANGUARD GROUP INC | 08/13/2024 | 5.50 M | $237.02 M | -1.35% | 9.68% |
| BLACKROCK INC. | 08/13/2024 | 4.86 M | $209.52 M | 4.31% | 8.55% |
| BELLEVUE GROUP AG | 08/14/2024 | 3.88 M | $167.29 M | -3.16% | 6.83% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 2.78 M | $119.76 M | 37.97% | 4.89% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 2.20 M | $94.70 M | -14.83% | 3.87% |
| STATE STREET CORP | 08/14/2024 | 2.11 M | $91.20 M | -32.61% | 3.72% |
| ARMISTICE CAPITAL, LLC | 08/14/2024 | 2.08 M | $89.65 M | -29.85% | 3.66% |
| JPMORGAN CHASE & CO | 08/12/2024 | 1.78 M | $76.59 M | -28.17% | 3.13% |
| MACQUARIE GROUP LTD | 08/09/2024 | 1.73 M | $74.59 M | -11.73% | 3.05% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 1.35 M | $58.29 M | 5.34% | 2.38% |
| BVF INC/IL | 08/14/2024 | 1.19 M | $51.32 M | 100.00% | 2.10% |
| MARSHALL WACE, LLP | 08/14/2024 | 1.13 M | $48.89 M | 307.82% | 2.00% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2024 | 1.04 M | $45.03 M | -40.82% | 1.84% |
| ARROWMARK COLORADO HOLDINGS LLC | 08/14/2024 | 1.02 M | $43.95 M | -32.90% | 1.79% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 07/30/2024 | 911,175 | $39.29 M | -17.81% | 1.60% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 08/15/2024 | 871,974 | $37.60 M | 66.67% | 1.54% |
| FISHER ASSET MANAGEMENT, LLC | 08/14/2024 | 709,912 | $30.61 M | 0.36% | 1.25% |
| D. E. SHAW & CO., INC. | 08/14/2024 | 678,234 | $29.25 M | 87.29% | 1.19% |
| DEUTSCHE BANK AG\ | 08/14/2024 | 662,236 | $28.56 M | -0.76% | 1.17% |
| MORGAN STANLEY | 08/14/2024 | 596,675 | $25.73 M | -49.45% | 1.05% |
| GW&K INVESTMENT MANAGEMENT, LLC | 08/12/2024 | 595,066 | $25.66 M | -8.36% | 1.05% |
| NORTHERN TRUST CORP | 08/14/2024 | 586,266 | $25.28 M | -0.72% | 1.03% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 549,003 | $23.67 M | 1.75% | 0.97% |
| CALIGAN PARTNERS LP | 08/14/2024 | 514,711 | $22.19 M | 6.19% | 0.91% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2024 | 464,121 | $20.01 M | 100.00% | 0.82% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 457,527 | $19.73 M | 3.93% | 0.81% |
| LOOMIS SAYLES & CO L P | 08/13/2024 | 448,863 | $19.36 M | 100.00% | 0.79% |
| PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2024 | 446,416 | $19.25 M | 100.00% | 0.79% |
| PICTET ASSET MANAGEMENT HOLDING SA | 08/13/2024 | 422,044 | $18.20 M | -58.03% | 0.74% |
| EAGLE HEALTH INVESTMENTS LP | 08/13/2024 | 330,830 | $14.27 M | 0.00% | 0.58% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 326,780 | $14.09 M | -14.40% | 0.58% |
| CANDRIAM S.C.A. | 08/05/2024 | 322,882 | $13.92 M | 100.00% | 0.57% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 08/14/2024 | 320,531 | $13.82 M | 641.75% | 0.56% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 08/12/2024 | 320,467 | $13.82 M | 100.00% | 0.56% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 317,941 | $13.71 M | 103.67% | 0.56% |
| CENTERBOOK PARTNERS LP | 08/12/2024 | 249,311 | $10.75 M | 100.00% | 0.44% |
| LAURION CAPITAL MANAGEMENT LP | 08/14/2024 | 248,395 | $10.71 M | -31.90% | 0.44% |
| NORGES BANK | 08/14/2024 | 242,734 | $10.47 M | 100.00% | 0.43% |
| AXA S.A. | 08/14/2024 | 238,682 | $10.29 M | -10.06% | 0.42% |
| NORDEA INVESTMENT MANAGEMENT AB | 08/08/2024 | 224,855 | $9.87 M | -15.65% | 0.40% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2024 | 223,979 | $9.66 M | -16.73% | 0.39% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 223,151 | $9.62 M | 13.88% | 0.39% |
| TD ASSET MANAGEMENT INC | 08/02/2024 | 210,472 | $9.08 M | 34.56% | 0.37% |
| JANE STREET GROUP, LLC | 08/15/2024 | 176,815 | $7.62 M | 41.98% | 0.31% |
| PANAGORA ASSET MANAGEMENT INC | 07/29/2024 | 174,870 | $7.54 M | 100.00% | 0.31% |
| TREXQUANT INVESTMENT LP | 08/13/2024 | 155,076 | $6.69 M | 155.53% | 0.27% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 08/14/2024 | 137,844 | $5.94 M | 54.87% | 0.24% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 08/14/2024 | 136,838 | $5.90 M | 100.00% | 0.24% |
| ASSENAGON ASSET MANAGEMENT S.A. | 07/18/2024 | 134,980 | $5.82 M | -70.32% | 0.24% |
Agios Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of AGIO shares?
During the previous two years, 299 institutional investors and hedge funds held shares of Agios Pharmaceuticals, Inc.. The most heavily invested institutionals were:
FARALLON CAPITAL MANAGEMENT LLC: 5.65 M
VANGUARD GROUP INC: 5.5 M
BlackRock Inc.: 4.86 M
Bellevue Group AG: 3.88 M
PRICE T ROWE ASSOCIATES INC /MD/: 2.78 M
DIMENSIONAL FUND ADVISORS LP: 2.2 M
-
What percentage of Agios Pharmaceuticals, Inc. stock is owned by institutional investors?
98.38% of Agios Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at AGIO ?
Institutional investors have bought a total of 69.35 M shares in the last 24 months. This purchase volume represents approximately $2.87 B in transactions.